VISION-2

PJ Devereaux

Deputy Director, Senior Scientist

Devereaux is a cardiologist, perioperative care physician, and clinical epidemiologist. He is the Director of the Division of Perioperative Care at McMaster University and a Deputy Director, Senior Scientist, and Scientific Leader of the Anesthesiology, Perioperative Medicine, and Surgical Research Group at PHRI. He is the Nominated Principal Applicant of the Accelerating Clinical Trials (ACT) Consortium, which is the Pan-Canadian Clinical Trials Consortium funded by the Canadian Institutes of Health Research (CIHR). Additionally, he holds a Tier 1 Canadian Research Chair in Perioperative Medicine.

Devereaux is a full Professor at McMaster University and the President of the Society of Perioperative Research and Care. He has published over 450 peer-reviewed papers and more than 85 book chapters, editorials, and commentaries, including 17 in the New England Journal of Medicine, 13 in the Lancet, and 11 in JAMA. He has an h-index of 115 and has given over 1000 lectures and research presentations in 41 countries. His research program focuses on major vascular complications during and after surgery, and he has led many large international randomized trials and prospective cohort studies on this topic.

Michael McGillion

Scientist

Michael McGillion is Associate Professor, and Assistant Dean, Research, at the School of Nursing, McMaster University. He is the Heart and Stroke Foundation/Michael G. DeGroote Endowed Chair in Cardiovascular Nursing Research, and the International Visiting Professor of Digital Health, at Coventry University in the UK.

He is an internationally-recognized researcher in the area of persistent forms of cardiac pain such as refractory angina and unrelieved chest pain following successful revascularization procedures. He was Chair of the Joint Canadian Cardiovascular Society – Canadian Pain Society guidelines for the management of refractory angina, funded by the Canadian Institutes of Health Research (CIHR). He is Principal Investigator of the largest CIHR-funded, international prospective cohort study to examine social and psychological predictors of chronic post-surgical pain following cardiac surgery. His research focuses on remote automated monitoring and virtual recovery support for people recovering from cardiac and vascular surgery, decision support for people living with RFA, and global-scale, web-based dissemination of new evidence on persistent forms of cardiac pain.

Mike has been recognized for his research and advocacy by receiving the Canadian Pain Society Early Career Award and the McMaster University Arch Award for outstanding contributions to society; and was the first University Scholar (2019) from the McMaster School of Nursing.

Sandra Ofori

Scientist

Sandra Ofori is a Scientist in the Perioperative and Surgery research group at PHRI, an Assistant Professor in McMaster University’s Department of Medicine (cardiology), and a general cardiologist in Hamilton Health Sciences and St Joseph’s hospital, Hamilton. Her research interests are in the areas of perioperative care and cardiovascular disease prevention.

Her current research program is focused on optimizing the health of patients undergoing surgery with a focus on perioperative smoking cessation and secondary prevention strategies. Ofori is actively involved in the conduct of large international perioperative clinical trials coordinated from PHRI and was the project officer of the Post Discharge after Surgery Virtual Care with Remote Automated Monitoring Technology (PVC-RAM) 1 and 3 trials and a Co-Investigator in the PVC-RAM-2 trial. She is leading the smoking cessation program in the perioperative care group and is the Co-PI of the PREVENT trial.

Ofori completed her residency training in Internal Medicine and Cardiology at the University of Port Harcourt, Nigeria. She holds a Master’s degree in Preventive Cardiology from the Imperial College, London UK, and completed a Perioperative Medicine fellowship and a PhD in Health Research Methodology (Clinical Epidemiology) from McMaster University both under the supervision of PHRI Senior Scientist PJ Devereaux. She was in the third cohort of the World Heart Federation Salim Yusuf Emerging Leaders Program that was focused on the reduction of the global burden of hypertension

Jessica Tyrwhitt

Program Director

Jessica Tyrwhitt has more than 10 years’ experience in coordinating and managing large, international clinical trials. She oversees interventional trials, registries, and observational research studies looking at primary and secondary prevention of cardiovascular disease in a variety of therapeutic areas, including cardiology, thrombosis, nephrology, cardio-oncology and diabetes.

She holds an Honours Bachelor of Science Degree & Business from the University of Waterloo.

Valerie Harvey

Associate Program Manager

Valerie Harvey is an Associate Program Manager with more than 12 years’ experience in clinical research at PHRI. She currently coordinates and manages interventional trials and observational studies in Digital Health in the areas of perioperative medicine and cardiac surgery. She holds a Bachelor of Science Degree (Honours) in Biological Sciences from Brock University.

Carley Ouellette

Research Fellow

Carley Ouellette is a PhD student at McMaster University, School of Nursing studying under the supervision of Dr. Michael McGillion (committee: Drs. Maura Marcucci; Sandra Carroll) and is a registered nurse working clinically in the Emergency Department, Juravinski Hospital, Hamilton Health Sciences.

Carley’s research focus is on digital health innovations, wearable technologies, and virtual care with remote patient monitoring. Carley is currently leading with Drs McGillion and Marcucci, the VERDICT-2 study partnering with Cloud DX to complete a verification and user-testing study using the Vitaliti continuous vital signs monitor. This study will include a sample of patients who have undergone surgery, their caregivers, nurses, and physicians.

Carley is also the Nursing Project Officer for the PVC-RAM 1,3, and SMArTVIEW studies.